A joint venture founded between a family office and a holding company is interested in Series A and B medical device companies in the U.S. and Western Europe that are near FDA approval. The firm is also open to Korean and Japanese companies. Typical check sizes range between USD $500k-1.5M, preferring to lead transactions. The firm will also co-invest with the family office’s other investment vehicles to secure right in late-stage revenue-generating companies with a clear path to exit within an 18-24 month time frame.
The firm is interested open to all classes of medical devices, but mainly focuses on human implants. Their core focus is in the neuromuscular space, including orthopedics and spine implants. They are also interested in cardiology, vascular devices, surgical devices, oncology biopharma. Currently, they are looking to expand their core area and look at more cardiovascular, arterial and peripheral devices. Companies should be near FDA approval with proven technology.
The firm requires to take a board seat, observer at minimum.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment